Nosocomial Infection Caused by Methicillin-Resistant ‎Staphylococcus Aureus in Palestine

2459's picture
Journal Title, Volume, Page: 
Microb Drug Resist. , 11(1):75-7
Year of Publication: 
2005
Authors: 
Abu-Zant A
Department of Biological Sciences, An-Najah N. University, Nablus, Palestine
Current Affiliation: 
Faculty of Medicine & Health Sciences, Department of Biomedical Sciences, An-Najah National University, Nablus, Palestine
Adwan K
Department of Biological Sciences, An-Najah N. University, Nablus, Palestine
Abu-Hasan N
Department of Biological Sciences, An-Najah N. University, Nablus, Palestine
Adwan G,
Department of Biological Sciences, An-Najah N. University, Nablus, Palestine
Jarrar N
Department of Biological Sciences, An-Najah N. University, Nablus, Palestine
Abu-Shanab B
Department of Biological Sciences, An-Najah N. University, Nablus, Palestine
Preferred Abstract (Original): 

This report presents the prevalence of Palestinian isolates of methicillin-resistant Staphylococcus aureus (MRSA) in nosocomial infections and their antibiotic resistant pattern. A total of 321 clinical isolates of S. aureus were identified from different patients. The prevalence of methicillin resistance among S. aureus isolates was 8.7% (28 isolates). Resistance rates of MRSA to other antibiotics were as follows: 82.1% resistant to erythromycin, 67.9% to clindamycin, 64.3% to gentamicin, and 32.1% to ciprofloxacin. No co-trimoxazole- and vancomycin-resistant isolates were identified in this study. The proportion of methicillin resistance was highest among S. aureus isolates associated with upper respiratory specimens (42.8%); the proportion of methicillin resistance was 39.3% among skin ulcer isolates, 10.7% among urinary tract infection isolates, and lowest among isolates associated with blood and prostate discharge (3.6% each).

AttachmentSize
Nosocomial Infection Caused by Methicillin-Resistant ‎Staphylococcus Aureus in Palestine23.56 KB